Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

NCT05504226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet
DRUG: Teneligliptin Placebo Oral Tablet

Sponsor

Handok Inc.